This was from a PDF see here-: https://www.smith-nephew.com/global/assets/pdf/products/surgical/strucsure_case study.pdf
This small bit caught my eye in case study one on page 1 of the PDF-:• At two years, resorption of the biomaterial is almost complete, and patient is pain-free.
That was back on the 18/7/2013 when this PDF was written.
As can be seen in my previous post, we supplied S&N with BTM back in 2012, I know US Government agencies seem to take forever to reach a conclusion, just look at BARDA? DARPA would be no exception, this STRUCSURE CP Macroporous Calcium Phosphate Bone Graft Substitute, may be no different, it may be that DARPA has held up sales in this area until it is approved by DARPA and then FDA approval? hope I am right about this?
strucsure_case study.pdf
Ann: Appendix 3B Leon Hoare, page-5
-
- There are more pages in this discussion • 18 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.64 |
Change
-0.010(0.38%) |
Mkt cap ! $1.823B | |||
| Open | High | Low | Value | Volume |
| $2.62 | $2.64 | $2.58 | $2.297M | 877.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2375 | $2.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.64 | 3584 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| PNV (ASX) Chart |